Avita (ROCO:4735) Marketable Securities: NT$237.2 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:4735 Avita Corp ROCO:4735
66 GF Score
Price NT$38.15
GF Value NT$32.04
Valuation Modestly Overvalued
! 8 Warning Signs
View Full Analysis

What is Avita Marketable Securities?

Avita ROCO:4735 +0.39% 66 Marketable Securities is NT$237.2 Mil as of Mar. 2026. GuruFocus rates ROCO:4735 with a GF Score™ of 66/100 and a GF Value™ of NT$32.04 (Modestly Overvalued). The stock has 8 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Avita's Marketable Securities for the quarter that ended in Mar. 2026 was NT$237.2 Mil.

Avita's annual Marketable Securities declined from Dec. 2023 (NT$116.2 Mil) to Dec. 2024 (NT$92.0 Mil) but then increased from Dec. 2024 (NT$92.0 Mil) to Dec. 2025 (NT$165.6 Mil).

Avita  (ROCO:4735) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Avita Marketable Securities Related Terms

Avita Marketable Securities Historical Data

* Premium members only.

The historical data trend for Avita's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Avita Marketable Securities Chart

Avita Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 72.50 58.91 116.17 92.00 165.55

Avita Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 85.77 93.37 106.71 165.55 237.21
ROCO:4735
66GF Score
Avita Corp ROCO:4735
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Avita Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of NT$237.2 Mil mean?
Avita (ROCO:4735) has a Marketable Securities of NT$237.2 Mil as of Mar. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Avita and its competitors.
Is Avita's Marketable Securities too high?
Avita's current Marketable Securities is NT$237.2 Mil. Overall, Avita has a GF Score™ of 66/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Avita's Marketable Securities compare to ABT and SYK?
Avita's Marketable Securities of NT$237.2 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Medical Devices & Instruments company?
A good Marketable Securities depends on the Medical Devices & Instruments industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Avita and its competitors. Avita's current Marketable Securities is NT$237.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avita stock overvalued right now?
Based on GuruFocus' analysis, Avita (ROCO:4735) is currently considered Modestly Overvalued. The stock's GF Value™ is NT$32.04, compared to a current price of NT$38.15 — trading 19.1% above its estimated fair value. The current Marketable Securities is NT$237.2 Mil. Avita's overall GF Score™ is 66/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Avita (ROCO:4735), the current Marketable Securities is NT$237.2 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Avita (ROCO:4735) Overvalued in 2026?

Based on GuruFocus' analysis, Avita stock appears to be overvalued. The current stock price of NT$38.15 is trading 19.1% above its estimated GF Value™ of NT$32.04. GuruFocus considers Avita to be Modestly Overvalued.

Key valuation signals for ROCO:4735:

  • Marketable Securities: NT$237.2 Mil
  • GF Value™: NT$32.04 vs. price of NT$38.15 (19.1% above fair value)
  • GF Score™: 66/100 with 8 warning signs

No single metric tells the full story. See the ROCO:4735 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Avita Business Description

Address No.78, Sec.1, Guangfu road, 9th floor, Sanchong district, New Taipei City, TWN, 24158
Avita Corp is a manufacturer of point-of-care health products designed for clinical and personal use. The company provides body composition analyzers, blood pressure monitors, blood glucose monitors, digital thermometers, and nasal care devices. Its products include a thermometer, nasal aspirator, blood pressure monitor arm, and wrist.
66GF Score

Get the complete analysis for ROCO:4735

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$38.15
Price
NT$32.04
GF Value